Lisa M. McShane
Molecular Biology · 2002–2021
A researcher in the Science corpus: 16 papers; trusts 20 researchers and is trusted by 16 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 55 citations into it; #2,934 of 17,773 by trust here, #4,273 by citations
- Statistics and Probability — 46 citations into it
- Genetics — 42 citations into it
- Economics and Econometrics — 19 citations into it
Whom Lisa M. McShane trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Patrick M. M. Bossuyt
- Patrick Royston
- Willi Sauerbrei
- Johannes B Reitsma
- David W. Hosmer Jr.
- Jr. Frank E. Harrell
- Michael R. Chernick
Who trusts Lisa M. McShane overall
- Douglas G. Altman
- Joseph P. Romano
- Richard M. Simon
- Gary S. Collins
- Sanat K. Sarkar
- Nicolai Meinshausen
- R. Riley
- Jelle J. Goeman
- Karel G. M. Moons
- Jesse Hemerik
Papers from Lisa M. McShane's perspective
Ordered by how strongly the researchers Lisa M. McShane trusts endorse each paper. Same corpus, a different order for every researcher.
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (Annals of Internal Medicine)
- Dichotomizing continuous predictors in multiple regression: a bad idea (Statistics in Medicine)
- The challenge of subgroup analyses--reporting without distorting.
- Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
- Practical statistics for medical research
- Survival Analysis Part I: Basic concepts and first analyses (British Journal of Cancer)
- The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. (Clinical Chemistry)
- Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. (Journal of the American Medical Association (JAMA))
- Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Their papers
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005) — 764 citations
- Reporting recommendations for tumor marker prognostic studies. (2005) — 808 citations
- Controlling the number of false discoveries: application to high-dimensional genomic data (2004) — 296 citations
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (2003) — 2,085 citations
- A Paradigm for Class Prediction Using Gene Expression Profiles (2002) — 317 citations
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (2011) — 1,714 citations
- TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository (2021) — 384 citations
- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. (2020) — 1,200 citations
- Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group (2020) — 663 citations
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (2018) — 1,382 citations
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. (2016) — 711 citations
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012) — 879 citations
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). (2010) — 894 citations
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (2010) — 3,652 citations
- American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. (2010) — 1,006 citations
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2006) — 5,113 citations